![]() |
|
|

Department of Anatomy & Physiology, University of Dundee, Dundee DD1 4HN, Scotland, UK;
*
Department of Sports Science, South Bank University, London, UK; and
Human Muscle Metabolism Research Group, Loughborough University, Loughborough, UK
3To whom correspondence should be addressed. E-mail: m.j.rennie{at}dundee.ac.uk.
| ABSTRACT |
|---|
|
|
|---|
-ketoglutarate to the
mitochondrion. We hypothesized that glutamine might be a more efficient
anaplerotic precursor than endogenous glutamate alone. Indeed, a
greater expansion of the sum of muscle citrate, malate, fumarate and
succinate concentrations was observed at the start of exercise (70%
VO2max) after oral glutamine than when placebo or ornithine
-ketoglutarate was given. However, neither endurance time nor the
extent of phosphocreatine depletion or lactate accumulation during the
exercise was altered, suggesting either that TCA intermediates were not
limiting for energy production or that the severity of exercise was
insufficient for the limitation to be operational. We have also shown
that in the perfused working rat heart, there is a substantial fall in
intramuscular glutamine and
-ketoglutarate, especially after
ischemia. Glutamine (but not glutamate,
-ketoglutarate or aspartate)
was able to rescue the performance of the postischemic heart. This
ability appears to be connected to the ability to sustain intracardiac
ATP, phosphocreatine and glutathione.
KEY WORDS: glutamine glycogen storage glutathione glucosamine tricarboxylic acid cycle
| INTRODUCTION |
|---|
|
|
|---|
I (M. J. Rennie) became interested in the effects of glutamine on
carbohydrate metabolism after hearing Dieter Häussinger talk
about the effects of volume regulation, glutamine and hepatocyte
metabolism. Together with Peter Taylor and Sylvia Low, we investigated
the possibility that skeletal muscle also had the capacity for
modulation of metabolism via alteration of cell volume. We showed that
when myotubes were swollen, the rate of glycogen synthesis was
increased by
60% (Low et al. 1996a
). Furthermore, we
were able to show that glutamine addition would cause an increase in
cell volume (Low et al. 1996b
) and in glycogen synthesis
(Low et al.1996a
). Later work showed that application of
an ante-integrin antibody abolished the response, suggesting that
it was mediated via some cytoskeletal mechanism (Low and Taylor 1998
).
The idea that glutamine had an effect on carbohydrate metabolism in
muscle was fascinating, and an Italian visitor to our department
insisted on carrying out a study in which he infused glutamine to about
double the normal plasma concentration after exhausting exercise. The
change in muscle glycogen during recovery was then measured
(Varnier et al. 1995
). He was able to show that
glutamine concentration in muscle could be elevated (by only
15%
despite the
70% increase in plasma glutamine concentration). The
infusion of saline or alanine plus glycine (isoenergetic and
isonitrogenous to the glutamine infusion) was associated with a further
fall in intramuscular glutamine in the postexercise period. However,
most surprisingly, muscle glycogen concentration appeared to be
elevated in the glutamine-treated subjects compared with those
treated with saline or alanine plus glycine. Obviously this was not
simply a question of availability of gluconeogenic substrates because
the total amount of carbon provided as alanine and glycine was
equivalent to that in glutamine. However, the effect was, in absolute
terms, rather modest and was responsible for no more than 2
µmol/(g wet weight of glycogen · h). Exhausting
exercise followed by carbohydrate refeeding can produce rates of
glycogen storage that are at least three times this [reviewed in
Ivy (1991)
].
Nevertheless, we persisted in examining this phenomenon and Jo Bowtell
decided to see whether there was a practical method to promote
postexercise skeletal muscle glycogen storage in human beings. In
particular, she wanted to know whether oral administration was
effective, whether the stimulatory effects of glutamine and a
carbohydrate source were additive and whether nonmuscle glycogen
storage was modified (Bowtell et al. 1999
). Subjects
were studied after exhaustive exercise for 1.5 h at 70% of
VO2max whereupon they consumed a 330-mL drink
containing 8 g of glutamine alone or 18.5% glucose polymer (a
collection of oligosaccharides of glucose) or glutamine plus the
glucose polymer together. The same seven subjects were examined three
times, on each occasion with a muscle biopsy after exercise before a
primed constant infusion of [13C]glucose and 1
and 2 h after infusion. Oral administration of glutamine
increased plasma glutamine concentration (
50% at peak) although not
to the same extent as intravenous administration. Ingestion of
glutamine plus glucose polymer was less effective in promoting the
increase in plasma glutamine concentration, which on average, was
200300 µmol/L. As expected, plasma glucose and
insulin concentrations were elevated only in the trials in which
glucose polymer was given. Surprisingly there was no differential
effect on skeletal muscle glycogen storage among giving glutamine
alone, glucose polymer alone or glucose polymer and glutamine. The most
striking finding was a substantial promotion of whole-body
nonoxidative glucose disposal in the subjects given glucose polymer and
glutamine relative to those receiving glucose polymer or glutamine
alone. This suggested that the site of increased carbohydrate storage
was the liver, not skeletal muscle. This very puzzling result might be
explained by the observations of Baron et al. (1995)
and
Rossetti et al. (1995)
who showed that glucosamine,
which is produced in muscle via the hexosamine pathway from glucose in
the presence of glutamine, has marked inhibitory effects on glucose
transport and whole-body glucose disposal. Glucosamine infusion
reduces intrinsic activity of GLUT 4 within 2 h (Hawkins et al. 1999
) and decreases the recruitment of GLUT4 to the plasma
membrane (Baron et al. 1995
). It may be that in the
presence of glucose, the availability of substrate in muscle is,
paradoxically, reduced compared with situations in which glucose alone
or glutamine alone are given. However, this is a speculation we have
not yet tested.
| Glutamine, the Krebs cycle and exercise capacity |
|---|
|
|
|---|
-amidase reaction. In addition, of
course, there is also glutaminase, which provides glutamate that can be
oxidized to 2-oxoglutarate by glutamate dehydrogenase. There is no net
gain of TCAI from valine or isoleucine metabolism because
2-oxoglutarate is used in producing succinyl CoA, and leucine provides
acetyl CoA, which is completely oxidized. Thus, the branched-chain
amino acids cannot be anaplerotic substrates. The importance of
glutamate as an anaplerotic substrate is hinted at by the work of
Sahlin et al. (1995)
The strategy adopted was to deplete subjects of glycogen by prior
exercise and a low carbohydrate diet, so that the glycogen availability
would be identically low in all trials. Subjects were then provided
with a drink of either a placebo or two small anaplerotic precursors
(ornithine
-ketoglutarate or glutamine both at 0.125 g/kg); then the
effects of bicycle exercise at 70% VO2max were
studied with appropriate muscle biopsies (Bruce et al. 2000
). The results were interesting because they challenged
some of our preconceptions. First, there was absolutely no difference
between treatments in the availability of intramuscular glutamate and
very little difference in plasma glutamate concentration, although
rather surprisingly, the glutamine treatment did in fact elevate plasma
glutamate concentration more than ingestion of ornithine
-ketoglutarate. There was the expected fall in muscle glutamate
content during the first 10 min of exercise but the extent of the fall
was identical among the three treatments (
11 mmol/kg dry
muscle). However, at 10 min of exercise, glutamine
administration did cause a substantial rise in the availability of
TCAI, whereas ornithine
-ketoglutarate had no significant effect.
Nevertheless, Krebs cycle flux appeared to be unaltered because the
fall in phosphocreatine and the rise in muscle lactate concentration
were not significantly different among trials. When we examined the
exercise-related changes between 10 min and exhaustion, there
appeared at first to be some slight advantage of having taken glutamine
and some disadvantage in taking ornithine
-ketoglutarate; in fact,
the mean times taken to reach exhaustion were not different. Despite
the fact that the TCAI concentrations had been higher in the
glutamine-treated group at 10 min of exercise, all three groups had
identical TCAI concentrations at exhaustion. Thus it appears that it is
possible to increase the availability of TCAI without any effect on
oxidative capacity or exercise capacity. There was no relationship
whatsoever between endurance capacity and TCAI pool size at 10 min or
fatigue.
| Glutamine and cardiac performance in metabolism |
|---|
|
|
|---|
2.5 mmol glutamine in the perfusate
and seemed to include not only cardioprotection but rescue, i.e., the
provision of glutamine after the ischemic or anoxic episode would
result in restitution of performance. The effect appeared to be
connected to the preservation of intracardiac glutamate because
perfusion in the presence of glucose only would lead to substantial
depletion of glutamate, whereas perfusion with 0.6 mmol glutamine would
maintain cardiac glutamine and cardiac performance. In fact we showed
that in the postischemic period, glutamine was superior to aspartate,
glutamate and
-ketoglutarate, although the last-mentioned came
close to restoration of performance after a substantial lag period
(Khogali et al. 1997Most recently we demonstrated that in addition to this ATP effect, the ratio of reduced to oxidized glutathione concentration is also maintained in glutamine-reperfused hearts. As yet, we have no information concerning whether this is a substrate effect or related to the energy potential of the heart in terms of ATP and phosphocreatine.
| FOOTNOTES |
|---|
2 Supported by the Wellcome Trust, the Medical
Research Council of the United Kingdom, the British Heart Foundation,
the Nuffield Foundation, Ajinomoto, SmithKline Beecham, Kabi Fresenius,
and the Universities of Dundee, Nottingham and Loughborough. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Baron A. D., Zhu J.-S., Zhu J.-H., Weldon H., Maianu L. & Garvey W. T. (1995) Glucosamine induces insulin resistance in vivo by affecting Glut 4 translocation in skeletal muscle. J. Clin. Investig. 96:2792-2801.
2.
Bowtell J. L., Gelly K., Jackman M. L., Patel A., Simeoni M. & Rennie M. J. (1999) Effect of oral glutamine on whole body carbohydrate storage during recovery from exhaustive exercise. J. Appl. Physiol. 86:1770-1777.
3. Bruce M., Constantin-Teodosiu D., Greenhaff P. L., Boobis L. H., Williams C. & Bowtell J. L. (2000) Effect of glutamine and ornithine alpha-ketoglutarate supplementation on tricarboxylic acid cycle intermediates (TCAI) pool size. FASEB J 14:A92(abs.).
4. Gibala M. J., Maclean D. A., Graham T. E. & Saltin B. (1998) Tricarboxylic acid intermediate pool size and estimated cycle flux in human muscle during exercise. Am. J. Physiol. 275:E235-E242.
5.
Hawkins M., Hu M., Yu J., Eder H., Vuguin P., She L., BArzilai N., Leiser M., Backer J. M. & Rossetti L. (1999) Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 274:31312-31319.
6. Ivy J. L. (1991) Muscle glycogen synthesis before and after exercise. Sports Med 11:6-19.[Medline]
7. Khogali S. O., Harper A. A., Lyall J. A. & Rennie M. J. (1998a) Effects of L-glutamine on postischaemic cardiac function: protection and rescue. J. Mol. Cell. Cardiol. 30:819-827.[Medline]
8. Khogali S. O., Lyall J. A., Harper A. A. & Rennie M. J. (1997) Glutamine is superior to glutamate in enhancing post-ischaemic recovery of the isolated perfused working rat heart. J. Physiol. 501P:127.
9. Khogali S.E.O., Weryk B., Lyall J. A. & Rennie M. J. (1998b) Post-ischaemic reperfusion with glutamine, but not glutamate or aspartate, enhances glutathione reduction state in the isolated working rat heart. Proc. Phys. Soc. 513P:160.
10. Low S. Y., Rennie M. J. & Taylor P. M. (1996a) Modulation of glycogen synthesis in rat skeletal muscle by changes in cell volume. J. Physiol. 495:299-303.[Medline]
11.
Low S. Y. & Taylor P. M. (1998) Integrin and cytoskeletal involvement in signalling cell volume changes to glutamine transport in rat skeletal muscle. J. Physiol. 512:481-485.
12. Low S. Y., Taylor P. M. & Rennie M. J. (1996b) Responses of glutamine transport in cultured rat skeletal muscle to osmotically induced changes in cell volume. J. Physiol. 492:877-885.[Medline]
13. Rossetti L., Hawkins M., Chem W., Gindi J. & Barzilai N. (1995) In vivo glucosamine infusion induces insulin resistance in normoglycaemia but not in hyperglycaemic conscious rats. J. Clin. Investig. 96:132-140.
14. Sahlin K., Jorfeldt L., Henriksson K.-G., Lewis S. F. & Haller R. G. (1995) Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdles disease. Clin. Sci. (Lond.) 88:687-693.[Medline]
15.
Sahlin K., Katz A. & Broberg S. (1990) Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am. J. Physiol. 259:C834-C841.
16.
Varnier M., Leese G. P., Thompson J. & Rennie M. J. (1995) Stimulatory effect of glutamine on glycogen accumulation in human skeletal muscle. Am. J. Physiol. 269:E309-E315.
This article has been cited by other articles:
![]() |
B. V. Bui, M. Kalloniatis, and A. J. Vingrys Retinal Function Loss after Monocarboxylate Transport Inhibition Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 584 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Bui, M. Kalloniatis, and A. J. Vingrys The Contribution of Glycolytic and Oxidative Pathways to Retinal Photoreceptor Function Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2708 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xia, H. Y. Wen, M. E. Young, P. H. Guthrie, H. Taegtmeyer, and R. E. Kellems Mammalian Target of Rapamycin and Protein Kinase A Signaling Mediate the Cardiac Transcriptional Response to Glutamine J. Biol. Chem., April 4, 2003; 278(15): 13143 - 13150. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||